数据媒体产品

Search documents
隽泰控股(00630.HK)7月16日收盘上涨11.67%,成交30.26万港元
Sou Hu Cai Jing· 2025-07-16 08:28
Company Overview - JunTai Holdings Limited is a company registered in Bermuda, primarily engaged in the manufacturing and sales of medical equipment, plastic molds, and data media products [2] Financial Performance - As of December 31, 2024, JunTai Holdings reported total revenue of 34.9969 million yuan, a year-on-year increase of 10.07% [1] - The company recorded a net profit attributable to shareholders of -1.1418 million yuan, reflecting a year-on-year growth of 55.21% [1] - The gross profit margin stood at 36.89%, while the debt-to-asset ratio was 62.26% [1] Stock Performance - On July 16, the Hang Seng Index fell by 0.29%, closing at 24,517.76 points [1] - JunTai Holdings' stock closed at 0.335 HKD per share, marking an increase of 11.67% with a trading volume of 901,900 shares and a turnover of 302,600 HKD [1] - Over the past month, JunTai Holdings has seen a cumulative increase of 316.67%, and a year-to-date increase of 150%, outperforming the Hang Seng Index by 22.58% [1] Industry Valuation - The average price-to-earnings (P/E) ratio for the healthcare equipment and services industry is -3.39 times, with a median of 1.17 times [1] - JunTai Holdings has a P/E ratio of -235.41 times, ranking 56th in the industry [1] - Comparatively, other companies in the sector have P/E ratios such as Star Medical Holdings at 0.26 times, Kingjoy Health at 0.38 times, and others ranging from 1.96 to 5.35 times [1]
隽泰控股(00630.HK)7月11日收盘上涨9.62%,成交32.15万港元
Jin Rong Jie· 2025-07-11 08:33
Group 1 - The core viewpoint of the article highlights the significant stock performance of JunTai Holdings, with a recent increase of 465.22% over the past month and 116.67% year-to-date, outperforming the Hang Seng Index by 19.78% [1] - As of December 31, 2024, JunTai Holdings reported total revenue of 34.9969 million yuan, a year-on-year increase of 10.07%, and a net profit attributable to shareholders of -1.1418 million yuan, reflecting a year-on-year growth of 55.21% [1] - The company's gross profit margin stands at 36.89%, with a debt-to-asset ratio of 62.26% [1] Group 2 - JunTai Holdings operates primarily in the manufacturing and sales of medical equipment products, plastic molds, and data media products, having expanded its medical equipment business through the acquisition of the Titron Group in October 2011 [2] - The average price-to-earnings (P/E) ratio for the healthcare equipment and services industry is -2.68 times, with a median of 1.17 times, while JunTai Holdings has a P/E ratio of -204.03 times, ranking 56th in the industry [1] - Comparatively, other companies in the industry have P/E ratios such as Giant Medical Holdings at 0.28 times, Jingjiu Health at 0.38 times, Yihui Group at 1.96 times, Global Medical at 5.24 times, and Ruici Medical at 5.4 times [1]
隽泰控股(00630.HK)6月12日收盘上涨39.13%,成交1.42万港元
Sou Hu Cai Jing· 2025-06-12 08:35
Group 1 - The Hang Seng Index closed down 1.36% at 24035.38 points on June 12, with JunTai Holdings (00630.HK) closing at HKD 0.064 per share, up 39.13% with a trading volume of 250,000 shares and a turnover of HKD 14,200 [1] - Over the past month, JunTai Holdings has shown a cumulative increase of 0%, while it has a year-to-date decline of 61.67%, underperforming the Hang Seng Index by 21.47% [1] - Financial data as of December 31, 2024, indicates that JunTai Holdings achieved total revenue of HKD 34.9969 million, a year-on-year increase of 10.07%, and a net profit attributable to shareholders of -HKD 1.1418 million, a year-on-year increase of 55.21%, with a gross margin of 36.89% and a debt-to-asset ratio of 62.26% [1] Group 2 - Currently, there are no institutional investment ratings for JunTai Holdings [2] - The average price-to-earnings (P/E) ratio for the healthcare equipment and services industry (TTM) is -21.87 times, with a median of 0.4 times; JunTai Holdings has a P/E ratio of -36.1 times, ranking 65th in the industry [2] - Other companies in the industry include Jingjiu Kangliao (00648.HK) with a P/E ratio of 0.38 times, Juxing Medical Holdings (02393.HK) at 0.42 times, Yongsheng Medical (01612.HK) at 3.87 times, Global Medical (02666.HK) at 4.7 times, and Ruici Medical (01526.HK) at 5.45 times [2]
隽泰控股(00630.HK)5月23日收盘上涨42.86%,成交3840港元
Jin Rong Jie· 2025-05-23 08:30
Company Overview - JunTai Holdings Limited is a company registered in Bermuda and listed on the Hong Kong Stock Exchange since 1996, primarily engaged in the manufacturing and sales of medical equipment, plastic molds, and data media products [2] Financial Performance - As of December 31, 2024, JunTai Holdings reported total revenue of 34.9969 million yuan, representing a year-on-year growth of 10.07% [1] - The company recorded a net profit attributable to shareholders of -1.1418 million yuan, showing a year-on-year increase of 55.21% [1] - The gross profit margin stood at 36.89%, while the debt-to-asset ratio was 62.26% [1] Stock Performance - On May 23, the Hang Seng Index rose by 0.24%, closing at 23,601.26 points, while JunTai Holdings' stock price increased by 42.86% to 0.06 HKD per share, with a trading volume of 65,300 shares and a turnover of 3,840 HKD [1] - Over the past month, JunTai Holdings has experienced a cumulative decline of 16%, and a year-to-date decline of 65%, underperforming the Hang Seng Index's increase of 17.37% [1] Industry Valuation - The average price-to-earnings (P/E) ratio for the healthcare equipment and services industry is -19.66 times, with a median of 0.31 times [1] - JunTai Holdings has a P/E ratio of -32.96 times, ranking 65th in the industry [1] - Other companies in the industry include Giant Medical Holdings (0.25 times), Jingjiu Health (0.38 times), Yongsheng Medical (4.01 times), Global Medical (4.58 times), and Ruici Medical (5.4 times) [1]
隽泰控股(00630.HK)4月14日收盘上涨12.73%,成交5050港元
Sou Hu Cai Jing· 2025-04-14 08:28
Company Overview - JunTai Holdings Limited is a Bermuda-registered company primarily engaged in the manufacturing and sales of medical equipment, plastic molds, and data media products [3] - The company expanded its medical equipment and plastic mold manufacturing business through the acquisition of the Titron Group in October 2011 [3] Financial Performance - As of December 31, 2024, JunTai Holdings reported total revenue of 34.9969 million yuan, representing a year-on-year growth of 10.07% [2] - The company recorded a net profit attributable to shareholders of -1.1418 million yuan, showing a year-on-year increase of 55.21% [2] - The gross profit margin stood at 36.89%, while the debt-to-asset ratio was 62.26% [2] Stock Performance - Over the past month, JunTai Holdings has experienced a cumulative decline of 22.54%, and a year-to-date decline of 54.17%, underperforming the Hang Seng Index, which has risen by 4.26% [2] - As of April 14, the stock price was 0.062 HKD per share, reflecting a 12.73% increase with a trading volume of 80,000 shares and a turnover of 5,050 HKD [1] Valuation Metrics - Currently, there are no institutional investment ratings for JunTai Holdings [3] - The company's price-to-earnings (P/E) ratio is -43.16, ranking 60th in the industry, compared to the average P/E ratio of -22.01 for the healthcare equipment and services sector [3] - Other companies in the same sector have P/E ratios such as Giant Medical Holdings at 0.17, Jingjiu Health at 0.38, and others ranging up to 4.97 [3]